Cardiac Aging and Mitochondrial Dysfunction: Implications for Cardiovascular Disease

Q: What is the clinical evidence from this study?

Study design: Systematic Review. Population: Cardiac aging and cardiovascular disease. Intervention: Mitochondrial dysfunction vs. Normal mitochondrial function. Primary outcome: Pathogenesis and progression of cardiac aging and cardiovascular disease.

Q: What does this research mean for the field?

Mitochondrial dysfunction, characterized by mtDNA mutations, altered mtDNA copy number, and impaired methylation, drives cardiac aging and predicts cardiovascular disease progression. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

doi:10.25258/ijddt.16.77s.14

October 22, 2026International Journal of Drug Delivery TechnologyOpen Access

Cardiac Aging and Mitochondrial Dysfunction: Implications for Cardiovascular Disease

View Full Paper

Ask AI

Bookmark

Share

Key result

Mitochondrial dysfunction drives cardiac aging and predicts cardiovascular disease progression.

Why the study?

Cardiac aging is a major risk factor for cardiovascular diseases, and understanding its underlying molecular mechanisms, particularly mitochondrial dysfunction, is crucial for developing effective anti-aging treatments.

Key Points

To review the molecular processes driving cardiac aging, focusing on the role of mitochondrial dysfunction, oxidative damage, and genetic alterations in cardiovascular disease pathogenesis.
Narrative review synthesizing findings from pre-clinical models, including dog, fruit fly, and mice, alongside human observational data.
Assessed mitochondrial pathways encompassing transfer RNA mutations, DNA methylation, reactive oxygen species generation, and mitochondrial DNA copy number variations.
Mitochondrial transfer RNA mutations impair respiratory chain function, with the 3253 T > C mutation causing a 66% reduction in ATP synthesis, altered complexes I and V activity, and elevated reactive oxygen species.
Oxidative base damage such as 8-oxo-guanine accumulation and reduced proofreading capacity of Pol gamma promote mitochondrial DNA deletions and mutations during cardiac senescence.
In murine models, excessive expression of mitochondrial transcription factor A and Twinkle mtDNA helicase resulted in a doubling of mtDNA copy number and alleviation of cardiac muscle cell injury.

Study Design

Type

Systematic Review

Structured PICO

P

Population

Preclinical and clinical studies published up to October 2023 examining cardiac aging, mitochondrial dysfunction, and cardiovascular diseases.

O

Outcome

Qualitative synthesis of molecular processes underlying cardiac aging, including mitochondrial dysfunction, oxidative stress, mitochondrial DNA mutations, mtDNA copy number, calcium regulation, and DNA methylation in the pathogenesis of cardiovascular diseasesurrogate

This systematic review synthesizes the molecular mechanisms linking mitochondrial dysfunction, oxidative stress, and mtDNA alterations to cardiac aging, highlighting potential diagnostic biomarkers and therapeutic targets for age-related cardiovascular diseases.

Limitations

Preclinical mouse model findings often do not translate effectively to humans due to genetic and biological differences
Interventions such as nutrition and exercise may not yield universal benefits across individuals and genders
Referenced clinical studies evaluating mtDNA copy number had relatively small sample sizes
Some referenced trials evaluating mitochondrial DNA copy number had relatively small sample sizes.
The precise molecular processes linking mitochondrial DNA mutations and methylation to various cardiovascular diseases have yet to be fully elucidated.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Mitochondrial targets merit biomarker exploration; leaves open whether modulating mtDNA or methylation improves clinical outcomes.

Abstract

Cardiac aging is a major risk factor for cardiovascular diseases (CVD), and understanding its underlying mechanisms is crucial for developing effective anti-aging treatments.This review paper provides a comprehensive overview of the molecular processes underlying cardiac aging, with a focus on mitochondrial dysfunction and its role in CVD.We examine the contributions of various pre-clinical models, including dog, fruit fly, and mice, to our understanding of cardiac aging processes.The review also explores the intricate interplay between mitochondrial dysfunction, oxidative stress, and age-related changes in cardiovascular tissues.We discuss the potential of mitochondrial DNA copy number, energy generation, calcium regulation, and DNA methylation as diagnostic and therapeutic targets in metabolic and cardiovascular disorders.The review also highlights the complex relationship between mitochondrial dysfunction and CVD, including the role of oxidative stress, DNA mutations, and impaired oxidative phosphorylation.Ultimately, this review aims to provide a comprehensive understanding of the molecular processes underlying cardiac aging and the pivotal role of mitochondrial dysfunction in the pathogenesis of CVD.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

A 2026 study conducted a systematic review in Cardiac aging and cardiovascular disease. Mitochondrial dysfunction vs. Normal mitochondrial function was evaluated on Pathogenesis and progression of cardiac aging and cardiovascular disease. Mitochondrial dysfunction, including mtDNA mutations, altered mtDNA copy number, and impaired methylation, drives cardiac aging and predicts cardiovascular disease progression.

synapsesocial.com/papers/6ae28e94cbadf70daf6c4387 https://doi.org/10.25258/ijddt.16.77s.14

View Full Paper

Ask AI

Bookmark

Share

Cardiac Aging and Mitochondrial Dysfunction: Implications for Cardiovascular Disease

Key Points

Study Design

Structured PICO

Limitations

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Cardiac Aging and Mitochondrial Dysfunction: Implications for Cardiovascular Disease

Key Points

Study Design

Structured PICO

Limitations

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading